Can ovarian malignant tumors be cured?

Whether ovarian malignant tumors can be cured depends on tumor stage, pathological type and individual differences. Early detection and standardized treatment can significantly increase the probability of cure.

The therapeutic effect of ovarian malignant tumors is closely related to the stage of the disease at diagnosis. Patients with stage one ovarian cancer have a higher five-year survival rate through comprehensive staging surgery combined with chemotherapy. When the tumor is limited to one or both ovaries and the capsule is intact, adjuvant platinum chemotherapy drugs such as carboplatin injection and paclitaxel injection can effectively control the disease after complete resection of the lesion. Patients with pathological types of low-grade serous carcinoma or mucinous carcinoma have a relatively good prognosis, and regular postoperative review of tumor markers and imaging examinations can help monitor recurrence.

Treatment of advanced ovarian malignant tumors is significantly more difficult. Patients with stage III or above often develop peritoneal dissemination or distant metastasis and require cytoreductive surgery combined with neoadjuvant chemotherapy. Although the use of targeted drugs such as bevacizumab injection and olaparib tablets can prolong progression-free survival, most patients will experience platinum resistance relapse. Special pathological types such as high-grade serous carcinoma or undifferentiated carcinoma are highly invasive and prone to extensive pelvic infiltration and lymphatic metastasis, and are prone to recurrence even after multiple lines of treatment.

Standardized treatment requires an individualized plan based on the patient's age, fertility needs and genetic testing results. Patients with BRCA gene mutations may consider maintenance therapy with PARP inhibitors. During treatment, it is necessary to monitor changes in tumor markers such as CA125 and evaluate the efficacy in conjunction with pelvic MRI. After treatment, you should maintain a low-fat and high-protein diet, supplement vitamin D and calcium in an appropriate amount, and avoid strenuous exercise that may cause postoperative adhesions. It is recommended to review every three months. No recurrence within five years can be regarded as clinical cure.